Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Change in Receivables (2016 - 2025)

CV Sciences (CVSI) has disclosed Change in Receivables for 13 consecutive years, with $6000.0 as the latest value for Q4 2025.

  • Quarterly Change in Receivables fell 94.17% to $6000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$124000.0 through Dec 2025, down 247.62% year-over-year, with the annual reading at -$124000.0 for FY2025, 247.62% down from the prior year.
  • Change in Receivables hit $6000.0 in Q4 2025 for CV Sciences, up from -$142000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $610000.0 in Q3 2021 to a low of -$1.1 million in Q1 2022.
  • Historically, Change in Receivables has averaged -$23400.0 across 5 years, with a median of $25500.0 in 2023.
  • Biggest five-year swings in Change in Receivables: tumbled 724.06% in 2022 and later surged 382.61% in 2024.
  • Year by year, Change in Receivables stood at $294000.0 in 2021, then crashed by 63.61% to $107000.0 in 2022, then crashed by 332.71% to -$249000.0 in 2023, then surged by 141.37% to $103000.0 in 2024, then plummeted by 94.17% to $6000.0 in 2025.
  • Business Quant data shows Change in Receivables for CVSI at $6000.0 in Q4 2025, -$142000.0 in Q3 2025, and $112000.0 in Q2 2025.